The T-body approach: potential for cancer immunotherapy
- 1 January 1996
- journal article
- Published by Springer Science and Business Media LLC in Springer Seminars in Immunopathology
- Vol. 18 (2), 199-209
- https://doi.org/10.1007/bf00820666
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- T-Bodies: Chimeric T-Cell Receptors with Antibody-Type SpecificityMethods, 1995
- Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genesEuropean Journal of Immunology, 1995
- New simplified molecular design for functional T cell receptorEuropean Journal of Immunology, 1993
- Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.The Journal of Experimental Medicine, 1993
- The hinge region of the CD8α chain: structure, antigenicity, and utility in expression of immunoglobulin superfamily domainsInternational Immunology, 1992
- Fc ReceptorsAnnual Review of Immunology, 1991
- Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptidesCell, 1991
- Chimeric immunoglobulin-T cell receptor proteins form functional receptors: Implications for T cell receptor complex formation and activationCell, 1990
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaThe New England Journal of Medicine, 1988
- Expression of chimeric receptor composed of immunoglobulin-derived V resions and T-cell receptor-derived C regionsBiochemical and Biophysical Research Communications, 1987